Novacyt FY15 financial results PR ENGLISH Paris, France and Cambridge, UK – 12 May 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces the...
Novacyt St Stephen's AIDS Trust clinical trial collaboration PR ENGLISH Paris, France and Cambridge, UK – 9 May 2016 – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease...
Novacyt Primerdesign Acquisition Update PR (25-4-16) ENGLISH Paris, France and Cambridge, UK – 25th April 2016, – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, announces it...
Paris, France and Cambridge, UK – 1st April 2016, – Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, updates the market on its intended acquisition of...
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, held Monday 22 February an Extraordinary General Meeting (“EGM”) related to the acquisition of Primerdesign Ltd (“Primerdesign”) and...
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has appointed MDL Asia Pty Ltd (“MDL” or “MDL Asia”) as its marketing and...
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, updates the market on its intended acquisition of Primerdesign Ltd (“Primerdesign”), a profitable and rapidly growing UK molecular...
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that Invest Securities, an independent investment banking and advisory group, based in Paris, has initiated research...
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has entered into a definitive agreement to acquire the entire share capital of Primer...
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its unaudited revenues for the full year to December 2015. Download press release...
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
